Featuring perspectives from Dr Matthew D Galsky, Prof Andrea Necchi and Dr Scott T Tagawa, including the following topics:
- Current and Future Management of Nonmetastatic Urothelial Bladder Cancer (UBC)
- Introduction (0:00)
- Management of non-muscle-invasive bladder cancer (5:30)
- Neoadjuvant and adjuvant therapy for muscle-invasive bladder cancer (18:39)
- Management of nonmetastatic UBC in patients who are not candidates for cystectomy (27:55)
- Recent Advances in the Treatment of Metastatic UBC (mUBC)
- Selection and sequencing of therapy for platinum-eligible patients with FGFR wild-type mUBC (31:03)
- Selection and sequencing of therapy for platinum-ineligible patients with FGFR wild-type mUBC (41:26)
- Selection and sequencing of therapy for patients with FGFR-altered mUBC (45:07)
- Novel agents and strategies under investigation in UBC (53:53)
CME information and select publications
